Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Painless Skin Patch for Direct Drug Delivery Could Eliminate Injections and Oral Medication

By HospiMedica International staff writers
Posted on 19 Oct 2023

A cost-effective microneedle skin patch that can administer the medication directly into the body might soon make injections or pills unnecessary. These patches which could be available for public use in the next five to 10 years may also be able to deliver vaccines and monitor hormone levels.

A research team led by scientists at the University of Bath (Bath, UK) has developed the unique microneedle patches using hydrogel, or a gel-like substance with water as its liquid component. Instead of a separate reservoir, the active ingredient is encapsulated within the hydrogel microneedle structure. The patch is also cheaper than other microneedle patches available in the market, primarily because it is made using 3D printed molds, which are easy to customize, thereby reducing the overall cost. The patch is smaller than a pound coin and features nearly invisible microneedles that painlessly penetrate the skin's initial surface layers. When these water-attracting ("hydrophilic") needles come into contact with bodily fluids below the skin, they swell and release a precise dosage of drug into the body.

Tests conducted at the University of Bath showed that the patch could effectively deliver antibiotics to combat two types of dangerous bacteria: E. coli and Staphylococcus aureus. Interestingly, the patch also has the ability to draw out small amounts of fluid from under the skin for medical testing, which could be useful for applications like monitoring lactate levels in patients with infections. The team continues to improve the design of these microneedle patches which can offer a superior method for drug delivery over conventional means. The researchers expect the patches to be versatile enough to administer medications that circulate the entire body or need to be more localized. The patches also have the potential to be used for delivering vaccines and monitoring hormone levels.

“We can also see there being a role for these patches in the health and wellness fields,” said Bath Chemical Engineer Dr. Hannah Leese. “I can picture the day people have microneedles under their smartwatches to detect fluctuations in the stress hormone, cortisol.”

Related Links:
University of Bath 

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
CPAP Machine
EcoStar Auto
New
Cylindrical Water Scanning System
SunSCAN 3D
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Trilogy Valve with locator technology is the only TAVI system approved for aortic regurgitation (Photo courtesy of JenaValve)

New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation

Aortic regurgitation is a condition in which the aortic valve does not close properly, allowing blood to flow backward into the left ventricle. This results in decreased blood flow from the heart to the... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.